CAP immunomodulatory adjuvant (Virogenics)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameCAP immunomodulatory adjuvant (Virogenics)
Drug Alias NameCAP adjuvant (Virogenics)
ClassificationBiologics
Mechanisms of ActionInterleukin-12 receptor stimulantsCluster of differentiation 8 stimulantsT-cell surface antigen CD4 agonists
TargetsT-cell surface antigen CD4Cluster of differentiation 8Interleukin-12 receptor
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVirogenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirogenics Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A